Kneat.com Inc. (KSI) Reports Robust Growth in Q4 and Full Year 2025 Financial Results
LIMERICK, Ireland, Feb. 25, 2026 – Kneat.com, Inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, has announced its financial results for the fourth quarter and full year ended December 31, 2025. All dollar amounts are presented in Canadian dollars unless otherwise stated.
“This past year reaffirmed the essential role we play in helping leading life sciences organizations operate with compliance, consistency, and efficiency. In 2025, we grew software revenue by 33%, added a record number of new customers, strengthened our teams, advanced our data-integrity platform, and began harnessing native AI to deliver even greater value. Enterprise software in life sciences is fundamentally a trust-driven business, and we are proud to have earned that trust through years of proven performance as the partner of choice for thousands of users across many of the world’s largest life sciences companies. With disciplined investment, improving operating efficiency, and a clear path to cash-flow breakeven, we remain focused on delivering enduring value to our customers and our shareholders,” said Eddie Ryan, Chief Executive Officer of Kneat.
Kneat enters 2026 with strong operational momentum. With a solid balance sheet and growing footprint in the pharmaceutical manufacturing supply chain, Kneat expects to outpace 2025’s incremental Annual Recurring Revenue (ARR). While typical second-half seasonality is anticipated, this growth combined with exceptional revenue retention reinforces Kneat’s proven durable growth model.
“Kneat continued to build a durable business throughout 2025, and our pipeline for 2026 looks promising. This includes new customers and expansions, including some projects that carried over from 2025. With this favorable set-up for a continued strong top line, and the teams and talent already in place at Kneat to execute, we have set a target of cash flow breakeven for the full year. This milestone equips us to keep creating value for life sciences well into the future,” added Dave O’Reilly, Chief Financial Officer of Kneat.
Eddie Ryan and Dave O’Reilly will host a conference call to discuss Kneat’s fourth-quarter and full-year 2025 results and hold a Q&A session for analysts and investors via webcast on Thursday, February 26, 2026, at 9:00 a.m. ET. Interested parties can register for the live webcast via the link provided on Inside Ticker.
Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform, Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by user-friendly design, expert support, and on-demand training academy. Kneat Gx is fully ISO 9001 and ISO 27001 certified, validated, and compliant with 21 CFR Part 11/Annex 11. Independent customer studies have shown that Kneat Gx reduces man-hours associated with validation documentation by up to 50%, accelerates review and approval cycles by up to 50%, and consistently supports higher standards of regulatory compliance.
For more information, visit www.kneat.com.